Andie Collier
Consigliere Generale presso GALERA THERAPEUTICS, INC.
Provenienza dei contatti di primo grado di Andie Collier
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 14 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Andie Collier tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Pharmaceuticals: Major | Director/Board Member | |
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bright Horizons Family Solutions LLC
Bright Horizons Family Solutions LLC Other Consumer ServicesConsumer Services Bright Horizons Family Solutions LLC provides early education and preschools, employer-sponsored child care, educational advisory, work and life solutions. Its educational advisory services segment includes college preparation and admissions counseling services as well as tuition reimbursement management and educational counseling services. The firm also provides back-up care solutions for children and elders, college counseling services and an array of other work life solutions for working families. The company was founded by Linda A. Mason and Roger H. Brown in 1986 and is headquartered in Newton, MA. | Other Consumer Services | Director/Board Member | |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Corporate Officer/Principal | |
SARcode Bioscience, Inc.
SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member | |
ANNEXON, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Virginia | College/University | Undergraduate Degree | |
California Pacific Medical Center
California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Drexel University | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Masters Business Admin Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Doctorate Degree | |
New York University | College/University | Corporate Officer/Principal | |
State University of New York at Buffalo | College/University | Doctorate Degree | |
University of California, Berkeley | College/University | Corporate Officer/Principal Masters Business Admin | |
University of California San Diego | College/University | Doctorate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Aspire IRB LLC
Aspire IRB LLC Miscellaneous Commercial ServicesCommercial Services Aspire IRB LLC operates as an independent review board that provides human subject protection oversight in clinical trials for life science companies. The private company is based in San Diego, CA and has subsidiaries in the United States. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Clarus Ventures LLC
Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
BLACKSTONE INC. | Investment Managers | Private Equity Investor | |
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member | |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital) is a private equity firm founded in 2013 by Garheng Kong and Randy L. Scott. The firm is headquartered in Redwood City, California. | Investment Managers | Private Equity Investor | |
UCSF School of Medicine | College/University | Corporate Officer/Principal | |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
PlanetVerify Ltd.
PlanetVerify Ltd. Packaged SoftwareTechnology Services PlanetVerify Ltd. provides electronic monetary transactions services. The company was founded by Owen Sorensen, Farmar Sean, and Heather Kennedy in 2013 and is headquartered in Dublin, Ireland. | Packaged Software | Director/Board Member | |
Silk Technologies Ltd.
Silk Technologies Ltd. Pharmaceuticals: MajorHealth Technology Silk Technologies Ltd. develops silk-derived protein (SDP) products for ophthalmic applications. Its patented SDP material is currently being developed as a compound for the treatment of patients with dry eye disease. The company was founded by Brian D. Lawrence and is headquartered in Plymouth, MN. | Pharmaceuticals: Major | Director/Board Member | |
Ophthalmology Innovation Summit
Ophthalmology Innovation Summit Financial ConglomeratesFinance Ophthalmology Innovation Summit provides investment services. The private company is based in Jericho. The American company was founded by Emmett T. Cunningham, Gilbert H. Kliman. | Financial Conglomerates | Founder | |
Oncopia Therapeutics, Inc.
Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Director/Board Member | |
Pr3vent, Inc
Pr3vent, Inc Medical/Nursing ServicesHealth Services Pr3vent, Inc provides healthcare technology services. The company was founded by Jochen Kumm and Darius M. Moshfegh and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Founder | |
Blackstone Life Sciences Advisors LLC
Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Esanik Therapeutics, Inc.
Esanik Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Esanik Therapeutics, Inc. develops treatments for cancer. | Miscellaneous Commercial Services | Director/Board Member | |
Medsyn Biopharma LLC
Medsyn Biopharma LLC BiotechnologyHealth Technology Medsyn Biopharma LLC develops therapeutics for cancer. The company was founded by Shaomeng Wang and is headquartered in Malvern, PA. | Biotechnology | Director/Board Member | |
LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Francis I Proctor Foundation | Corporate Officer/Principal | ||
CONTEXT THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Placid0, Inc.
Placid0, Inc. Packaged SoftwareTechnology Services Part of Ainsly Ltd., Placid0, Inc. develops a mobile platform for assessing ocular conditions. The company is based in Pasadena, CA. The company was founded in 2020 by Andrew Moshfeghi, Zach Bodnar, Darius M. Moshfeghi, Jochen Kumm, Emmett T. Cunningham. Placid0 was acquired by Ainsly Ltd. on February 10, 2022. | Packaged Software | Founder | |
CARISMA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 49 |
Regno Unito | 2 |
Irlanda | 2 |
Settori
Health Technology | 22 |
Consumer Services | 13 |
Commercial Services | 6 |
Finance | 6 |
Health Services | 4 |
Posizioni
Director/Board Member | 75 |
Corporate Officer/Principal | 40 |
Independent Dir/Board Member | 22 |
Chairman | 14 |
Chief Tech/Sci/R&D Officer | 11 |
Contatti più connessi
Insiders | |
---|---|
Michael Powell | 48 |
Emmett Cunningham | 29 |
Robert Beardsley | 17 |
J. Sorensen | 16 |
Jennifer Stacey | 12 |
Linda West | 12 |
Lawrence Alleva | 12 |
Eugene Kennedy | 9 |
Dennis P. Riley | 8 |
Kevin Lokay | 6 |
Jon T. Holmlund | 6 |
Chris Degnan | 6 |
Mark Bachleda | 5 |
Henning Thorsen | 3 |
- Borsa valori
- Insiders
- Andie Collier
- Connessioni Società